Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Toxicity”

431 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 431 results

Not applicableActive Not RecruitingNCT05708703
What this trial is testing

Assessing the Time Demands of Cancer

Who this might be right for
Metastatic Breast CancerOvarian Cancer
Masonic Cancer Center, University of Minnesota 78
Not applicableStudy completedNCT06856590
What this trial is testing

ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction

Who this might be right for
Hand-Foot Skin Reaction (HFSR)
Gazi University 150
Not applicableStudy completedNCT04659980
What this trial is testing

Preventing Taxane-related Peripheral Neuropathy, Pain and Nail Toxicity: A Prospective Self-controlled Trial Comparing Hilotherapy With Frozen Gloves in Early Breast Cancer

Who this might be right for
Breast Cancer
Universitaire Ziekenhuizen KU Leuven 62
Not applicableUnknownNCT05892146
What this trial is testing

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

Who this might be right for
Chemotherapeutic ToxicityCardiotoxicityHeart Failure+2 more
National Cheng-Kung University Hospital 100
Not applicableStudy completedNCT02171078
What this trial is testing

Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance

Who this might be right for
Breast Neoplasms
University of Wisconsin, Madison 34,359
Testing effectiveness (Phase 2)Study completedNCT02771353
What this trial is testing

The HeartSpare Plus 1B Trial

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 39
Not applicableLooking for participantsNCT06382818
What this trial is testing

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

Who this might be right for
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 854
Not applicableStudy completedNCT03858712
What this trial is testing

EHR-embedded OCDT in Breast or GI Cancer

Who this might be right for
Oral Cancer Directed TherapyBreast CancerGastrointestinal Cancer+1 more
Dana-Farber Cancer Institute 100
Not applicableEnded earlyNCT01243541
What this trial is testing

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

Who this might be right for
Chemotherapeutic Agent ToxicityPainPeripheral Neuropathy+9 more
Northwestern University 33
Not applicableUnknownNCT05917444
What this trial is testing

Managing Breast Cancer Treatment: Dyad's Perspectives on Treatment Decision, Financial and Family Burden.

Who this might be right for
Breast Cancer
National Taiwan University Hospital 224
Not applicableUnknownNCT04495387
What this trial is testing

Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy

Who this might be right for
Colon CancerBreast CancerChemotherapeutic Toxicity
University of Florence 100
Not applicableStudy completedNCT01727011
What this trial is testing

Single Fraction Elderly Breast Irradiation (SiFEBI)

Who this might be right for
Breast Cancer
Centre Antoine Lacassagne 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Large-scale testing (Phase 3)Study completedNCT00296036
What this trial is testing

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 137
Testing effectiveness (Phase 2)WithdrawnNCT04675450
What this trial is testing

NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy

Who this might be right for
Breast CancerPeripheral Neuropathy
Conjupro Biotherapeutics, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT00372723
What this trial is testing

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Who this might be right for
Toxic Epidermal Necrolysis
Loyola University
Testing effectiveness (Phase 2)Study completedNCT00119379
What this trial is testing

Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults

Who this might be right for
HIV InfectionsLipodystrophyMetabolic Diseases+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)UnknownNCT01331915
What this trial is testing

Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients

Who this might be right for
Melanoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 23
Not applicableStudy completedNCT01954836
What this trial is testing

Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial

Who this might be right for
NeoplasiaCancerFasting
Charite University, Berlin, Germany 50
Not applicableStudy completedNCT02393287
What this trial is testing

Retroprospective Real Life Observatory of Eribulin

Who this might be right for
Metastatic Breast Cancer
Institut Cancerologie de l'Ouest 753
Load More Results